FDA OKs 1st Gene Therapy, Kymriah, for Use in U.S.

WEDNESDAY, Aug. 30, 2017 — The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States.
Kymriah (tisagenlecleucel) genetically tweaks a patient’s own immune…
Source: Topamax